EB
REGN icon

Eastern Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Eastern Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$56.9K Buy
75
+18
+32% +$13.6K ﹤0.01% 611
2026
Q2 		$35.5K Buy
57
+13
+30% +$8.85K ﹤0.01% 669
2026
Q1 		$34K Buy
44
+14
+47% +$10.7K ﹤0.01% 633
2025
Q4 		$23.2K Buy
30
+20
+200% +$13.6K ﹤0.01% 701
2025
Q3 		$5.62K Sell
10
-15
-60% -$8.48K ﹤0.01% 895
2025
Q2 		$13.1K Hold
25
– – ﹤0.01% 730
2025
Q1 		$15.9K Buy
25
+5
+25% +$3.44K ﹤0.01% 727
2024
Q4 		$14.2K Hold
20
– – ﹤0.01% 735
2024
Q3 		$21K Buy
+20
New +$22.3K ﹤0.01% 677

Other funds holding REGN

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
JC
Jacobs & Co San Francisco, California $1.16B AUM 34.03% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
VC
Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

Eastern Bank's REGN Position: Q3 2026 in Review

Eastern Bank increased its Regeneron Pharmaceuticals (REGN) stake by 32% in Q3 2026, buying an estimated $13.6K and bringing the position to 75 shares worth $56.9K. The position accounts for ﹤0.01% of the portfolio, ranked #611.

Eastern Bank first reported a position in REGN in Q3 2024 and has held it in 9 quarters since. 54 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Eastern Bank held 75 shares of Regeneron Pharmaceuticals worth $56.9K as of Q3 2026.
  • Eastern Bank bought 18 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $13.6K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #611 holding.
  • Eastern Bank first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
  • 54 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.